Business Context and Reporting Period
SeaStar Medical Holding Corp (ICU) filed a Form 8-K on November 26, 2024, reporting the results of a special meeting of stockholders held virtually on the same date. The company is incorporated in Delaware and lists its common stock and warrants on The Nasdaq Stock Market LLC.
Key Financial Metrics
This filing is a current report regarding corporate governance and does not contain financial performance data. The text does not provide values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes and Voting Results
Stockholders approved three proposals at the special meeting:
- Proposal 1 (Nasdaq Proposal): Ratified the issuance of common stock upon conversion of certain convertible notes and exercise of certain warrants to maintain Nasdaq listing.
- Votes For: 1,404,488
- Votes Against: 48,859
- Abstentions: 1,783
- Broker Non-Votes: 1,112,485
- Proposal 2 (Authorized Share Proposal): Approved an amendment to the Certificate of Incorporation to reduce authorized common shares by 50,000,000 to a total of 450,000,000 shares.
- Votes For: 2,485,697
- Votes Against: 80,561
- Abstentions: 1,357
- Broker Non-Votes: None
- Proposal 3 (Adjournment): Approved a proposal to adjourn or postpone the meeting if necessary to solicit further votes for the other proposals.
- Votes For: 2,420,064
- Votes Against: 117,955
- Abstentions: 29,596
- Broker Non-Votes: None
Guidance, Outlook, and Risks
The filing does not contain management commentary, financial guidance, or specific risk factors beyond the context of maintaining Nasdaq listing compliance. The approval of the Nasdaq Proposal indicates the company is addressing listing requirements related to share issuance from convertible instruments.
Investor Verification Checklist
- Verify the impact of the authorized share reduction on future capital raising capabilities.
- Confirm the specific terms and conversion rates of the convertible notes and warrants ratified under Proposal 1.
- Review subsequent filings to ensure the company remains in compliance with Nasdaq listing standards following the vote.
- Check for any dilution effects resulting from the conversion of notes and exercise of warrants approved by stockholders.